Professor Michael Schmid is a research group leader and the Head of the Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK. He received his PhD from the University of Basel, Switzerland, and completed his postdoctoral training at the Moores Cancer Center, UCSD, USA. Professor Schmid’s lab focuses on the complex biology of pancreatic cancer metastasis. Metastasis is the leading cause of cancer-related death. Pancreatic ductal adenocarcinoma (PDAC) frequently metastasises to the liver und liver metastasis is accompanied by the formation of an inflammatory-fibrotic metastatic microenvironment that supports the colonisation and outgrowth of disseminated cancer cells. The main goal of his team is to gain a better understanding of where, when and how host immune cells enhance or suppress metastatic progression in pancreatic cancer, with the ultimate aim of identifying new therapeutic possibilities to defeat pancreatic cancer.
PhD-degree (summa cum laude), University of Basel, Switzerland, 2005.
Master in Biology, University of Bern,
For more information, please visit our lab website www.schmidlab.org